

Design, obtaining and preclinical assessment of Cuban anti-Covid Soberana 02 vaccine candidate reached the headlines of the US magazine ACS Chemical Biology, paving the way for other antiviral vaccines.

Cuba's Soberana 02 anti-Covid-19 vaccine was recognized by the prestigious U.S. medical journal Annual Review of Medicine, a step towards its possible international homologation.
Page 386 of 498